Press Release

Category Added in a WPeMatico Campaign

Business Wire13 October 2025

Palantir Technologies Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – PLTR

LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group announces that it is investigating claims on behalf of investors of Palantir Technologies Inc.…
Read More »
Business Wire13 October 2025

New Report by CAPS: Asian Philanthropy Positioned to Lead on Maternal and Child Health as Foreign Aid Retreats

The Centre for Asian Philanthropy and Society research examines unique approaches by domestic funders in China, India, Indonesia, and the…
Read More »
Business Wire12 October 2025

AdvanCell to Present Promising Clinical Trial Results of ADVC001, a Novel Lead-212-based PSMA-targeted Alpha Therapy for Prostate Cancer, at ESMO 2025

Results from the Phase 1b dose escalation of the TheraPb Phase 1/2 trial are the first clinical data for a…
Read More »
Cision PR Newswire12 October 2025

Caterpillar Inc. Enters Into Agreement to Acquire RPMGlobal

IRVING, Texas, Oct. 12, 2025 /PRNewswire/ — Caterpillar Inc. (NYSE: CAT) today entered into an agreement to acquire RPMGlobal Holdings Limited…
Read More »
Cision PR Newswire12 October 2025

Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib in Patients with NSCLC with EGFR mutations and Active Brain Metastases at the ESMO Congress 2025

PRINCETON, N.J. and CAMBRIDGE, Mass., Oct. 12, 2025 /PRNewswire/ — Taiho Oncology, Inc., and Cullinan Therapeutics, Inc., today announced new…
Read More »
Cision PR Newswire12 October 2025

IsoEnergy to Acquire Toro Energy, Strengthening a Top-Tier Uranium Portfolio in a Rising Market

TORONTO, Oct. 12, 2025 /PRNewswire/ – PERTH, Australia – Oct. 13, 2025 – IsoEnergy Ltd. (“IsoEnergy”) (NYSE American: ISOU) (TSX:…
Read More »
Business Wire12 October 2025

Natera to Present 14 Studies at ESMO, Including IMvigor011 Oral Presentation in Presidential Symposium

Six oral presentations highlight Signatera’s expanding role across solid tumors, including definitive predictive data in adjuvant bladder cancer AUSTIN, Texas–(BUSINESS…
Read More »
Business Wire12 October 2025

Anti-TIGIT Domvanalimab Plus Anti-PD-1 Zimberelimab and Chemotherapy Showed 26.7 Months of Median Overall Survival as First-Line Treatment of Unresectable or Advanced Gastroesophageal Adenocarcinomas in the Phase 2 EDGE-Gastric Study

First overall survival (OS) results from Arm A1 of the Phase 2 EDGE-Gastric study will be presented on October 18…
Read More »
Business Wire12 October 2025

Data from Incyte’s TGFβR2×PD-1 Bispecific Antibody and KRAS G12D Inhibitor to be Presented at the European Society of Medical Oncology (ESMO) Congress 2025

WILMINGTON, Del.–(BUSINESS WIRE)–$INCY #ESMO2025–Incyte (Nasdaq:INCY) today announced that results from Phase 1 proof-of-concept studies of INCA33890, a promising TGFβR2×PD-1-directed bispecific…
Read More »
Business Wire12 October 2025

AHF Commends Gov. Newsom for Signing PBM Reform Bill (SB 41, Weiner)

Legislation reforms will rein in drug middlemen abuses LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) thanked California Governor Gavin Newsom for…
Read More »

Previous page Next page